Company Overview of Evonik Industries AG
Evonik Industries AG operates as a specialty chemicals company worldwide. Its Consumer, Health, and Nutrition segment offers specialty chemicals primarily for consumer goods, animal nutrition, and pharmaceutical sectors, including fat chemistry products, quaternary derivatives, amphoteric surfactants, ceramides, phytosphingosines, organically modified silicones, and superabsorbents; and exclusive synthesis products, pharmaceutical polymers, amino acids and amino acid derivatives, and DL-methionine. The company’s Resource Efficiency segment provides inorganic materials consisting of organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, precipitated silicas, matting agents, precious...
Rellinghauser Strasse 1-11
Key Executives for Evonik Industries AG
Chairman of Management Board and Chief Executive Officer
Total Annual Compensation: $3.5M
Chief Financial Officer and Member of Executive Board
Total Annual Compensation: $313.0K
Chief Operating Officer and Member of Executive Board
Total Annual Compensation: $2.4M
Chief Human Resources Officer and Member of Executive Board
Total Annual Compensation: $2.3M
Compensation as of Fiscal Year 2013.
Evonik Industries AG Key Developments
Evonik Industries AG Announces to Build New Plant
Sep 24 14
Evonik Industries AG announced its plans to build a new plant for its polymethacrylimide structural foam ROHACELL in Shanghai, China, scheduled to begin operation in the fourth quarter of 2015. The new facility will be located in Evonik's Multi-User Site China (MUSC) in Shanghai Chemical Industry Park (SCIP). The lightweight material ROHACELL is already being used in Asia's aviation industry, including the regional jet ARJ21-700 and also the prototype of China's first large commercial airliner C919 that is scheduled to enter commercial service in 2018. ROHACELL high performance foam cores are ideal for the growing advanced composites industry and are enjoying increasing worldwide demand in not only the aviation industry, but also in automotive, electronics, medical technology and sporting goods.
Evonik Starts Up Expansion at Precipitated Silica Plant in US
Sep 10 14
Evonik announced that it has started up a 20,000 tonne/year expansion at its precipitated silica facility in Chester, Pennsylvania, in order to respond to growing demand for fuel-efficient tyres. The capacity addition in Chester was part of the company's initiative to increase worldwide capacities for precipitated silica by 30% since 2010.
Evonik Industries AG to Construct Plant to Produce Mepron® in Mobile
Aug 12 14
Evonik Industries AG announced that the company has begun construction of a new plant to produce Mepron® in Mobile (Alabama, USA). Mepron® is a special Evonik formulation of the amino acid methionine that is used in dairy cow nutrition. A special coating protects the amino acid from undesired degradation in the rumen. The new plant is scheduled for completion in the second half of 2015. The investment is in the low double-digit-million-euro range. When Mepron® is used in dairy cow rations, farmers can reduce the amount of crude protein in the feed with no adverse effect on performance. This lowers the total feed costs for the producer and increases the profitability of dairy cow farming.
Similar Private Companies By Industry
Recent Private Companies Transactions